ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell Line Development for Biologics Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-18N14405
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cell Line Development for Biologics Market Research Report 2023
BUY CHAPTERS

Global Cell Line Development for Biologics Market Research Report 2025

Code: QYRE-Auto-18N14405
Report
April 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Lonza
Corning Inc
Sartorius
Thermo Fisher Scientific
Selexis
Beckman Coulter (Danaher)
Cytena
Molecular Devices
Samsung Biologics
Hera BioLabs
GTP Bioways
Abzena
FyoniBio GmbH
Catalent
Wuxi Biologics

Cell Line Development for Biologics Market

The global market for Cell Line Development for Biologics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cell line development is a critical step in the production of biologics. Biologics are complex molecules that are produced by living cells, such as proteins, antibodies, and vaccines. To produce biologics in large quantities, scientists need to develop cell lines that can produce these molecules consistently and at high levels.
The global market for cell line development (CLD) in biologics has experienced substantial growth in recent years due to the increasing demand for biopharmaceutical products, including monoclonal antibodies, vaccines, and other therapeutic proteins. Cell line development is a critical step in the biomanufacturing process, involving the selection, optimization, and production of mammalian cell lines that can efficiently produce biologic drugs. The United States and Canada have a robust biopharmaceutical industry, making North America a major market for cell line development services. European countries have a significant presence in biologics development, with established pharmaceutical companies and research institutions driving demand for cell line development. The Asia-Pacific region is emerging as a key market due to its growing biopharmaceutical sector, increased investment in research and development, and access to skilled scientific talent. The cell line development for biologics market is projected to continue growing as biopharmaceutical companies strive to develop innovative and effective therapies. Technological advancements in automation, genomics, and synthetic biology are expected to further streamline and optimize the cell line development process.
This report aims to provide a comprehensive presentation of the global market for Cell Line Development for Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Line Development for Biologics.
The Cell Line Development for Biologics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell Line Development for Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Line Development for Biologics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cell Line Development for Biologics Market Report

Report Metric Details
Report Name Cell Line Development for Biologics Market
Segment by Type
  • CHO Cell Lines
  • HEK293 Cell Lines
  • Insect Cell Lines
Segment by Application
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lonza, Corning, Sartorius, Thermo Fisher Scientific, Selexis, Beckman Coulter (Danaher ), CYTENA, Molecular Devices, Samsung Biologics, Hera BioLabs, GTP Bioways, Abzena, FyoniBio, Catalent, WuXi Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cell Line Development for Biologics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cell Line Development for Biologics Market report?

Ans: The main players in the Cell Line Development for Biologics Market are Lonza, Corning, Sartorius, Thermo Fisher Scientific, Selexis, Beckman Coulter (Danaher ), CYTENA, Molecular Devices, Samsung Biologics, Hera BioLabs, GTP Bioways, Abzena, FyoniBio, Catalent, WuXi Biologics

What are the Application segmentation covered in the Cell Line Development for Biologics Market report?

Ans: The Applications covered in the Cell Line Development for Biologics Market report are Monoclonal Antibodies, Recombinant Proteins, Vaccines

What are the Type segmentation covered in the Cell Line Development for Biologics Market report?

Ans: The Types covered in the Cell Line Development for Biologics Market report are CHO Cell Lines, HEK293 Cell Lines, Insect Cell Lines

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Line Development for Biologics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CHO Cell Lines
1.2.3 HEK293 Cell Lines
1.2.4 Insect Cell Lines
1.3 Market by Application
1.3.1 Global Cell Line Development for Biologics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Monoclonal Antibodies
1.3.3 Recombinant Proteins
1.3.4 Vaccines
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell Line Development for Biologics Market Perspective (2020-2031)
2.2 Global Cell Line Development for Biologics Growth Trends by Region
2.2.1 Global Cell Line Development for Biologics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell Line Development for Biologics Historic Market Size by Region (2020-2025)
2.2.3 Cell Line Development for Biologics Forecasted Market Size by Region (2026-2031)
2.3 Cell Line Development for Biologics Market Dynamics
2.3.1 Cell Line Development for Biologics Industry Trends
2.3.2 Cell Line Development for Biologics Market Drivers
2.3.3 Cell Line Development for Biologics Market Challenges
2.3.4 Cell Line Development for Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Line Development for Biologics Players by Revenue
3.1.1 Global Top Cell Line Development for Biologics Players by Revenue (2020-2025)
3.1.2 Global Cell Line Development for Biologics Revenue Market Share by Players (2020-2025)
3.2 Global Cell Line Development for Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell Line Development for Biologics Revenue
3.4 Global Cell Line Development for Biologics Market Concentration Ratio
3.4.1 Global Cell Line Development for Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Line Development for Biologics Revenue in 2024
3.5 Global Key Players of Cell Line Development for Biologics Head office and Area Served
3.6 Global Key Players of Cell Line Development for Biologics, Product and Application
3.7 Global Key Players of Cell Line Development for Biologics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Line Development for Biologics Breakdown Data by Type
4.1 Global Cell Line Development for Biologics Historic Market Size by Type (2020-2025)
4.2 Global Cell Line Development for Biologics Forecasted Market Size by Type (2026-2031)
5 Cell Line Development for Biologics Breakdown Data by Application
5.1 Global Cell Line Development for Biologics Historic Market Size by Application (2020-2025)
5.2 Global Cell Line Development for Biologics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell Line Development for Biologics Market Size (2020-2031)
6.2 North America Cell Line Development for Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell Line Development for Biologics Market Size by Country (2020-2025)
6.4 North America Cell Line Development for Biologics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell Line Development for Biologics Market Size (2020-2031)
7.2 Europe Cell Line Development for Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell Line Development for Biologics Market Size by Country (2020-2025)
7.4 Europe Cell Line Development for Biologics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Line Development for Biologics Market Size (2020-2031)
8.2 Asia-Pacific Cell Line Development for Biologics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell Line Development for Biologics Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell Line Development for Biologics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell Line Development for Biologics Market Size (2020-2031)
9.2 Latin America Cell Line Development for Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell Line Development for Biologics Market Size by Country (2020-2025)
9.4 Latin America Cell Line Development for Biologics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Line Development for Biologics Market Size (2020-2031)
10.2 Middle East & Africa Cell Line Development for Biologics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell Line Development for Biologics Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell Line Development for Biologics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Cell Line Development for Biologics Introduction
11.1.4 Lonza Revenue in Cell Line Development for Biologics Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 Corning
11.2.1 Corning Company Details
11.2.2 Corning Business Overview
11.2.3 Corning Cell Line Development for Biologics Introduction
11.2.4 Corning Revenue in Cell Line Development for Biologics Business (2020-2025)
11.2.5 Corning Recent Development
11.3 Sartorius
11.3.1 Sartorius Company Details
11.3.2 Sartorius Business Overview
11.3.3 Sartorius Cell Line Development for Biologics Introduction
11.3.4 Sartorius Revenue in Cell Line Development for Biologics Business (2020-2025)
11.3.5 Sartorius Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Cell Line Development for Biologics Introduction
11.4.4 Thermo Fisher Scientific Revenue in Cell Line Development for Biologics Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Selexis
11.5.1 Selexis Company Details
11.5.2 Selexis Business Overview
11.5.3 Selexis Cell Line Development for Biologics Introduction
11.5.4 Selexis Revenue in Cell Line Development for Biologics Business (2020-2025)
11.5.5 Selexis Recent Development
11.6 Beckman Coulter (Danaher )
11.6.1 Beckman Coulter (Danaher ) Company Details
11.6.2 Beckman Coulter (Danaher ) Business Overview
11.6.3 Beckman Coulter (Danaher ) Cell Line Development for Biologics Introduction
11.6.4 Beckman Coulter (Danaher ) Revenue in Cell Line Development for Biologics Business (2020-2025)
11.6.5 Beckman Coulter (Danaher ) Recent Development
11.7 CYTENA
11.7.1 CYTENA Company Details
11.7.2 CYTENA Business Overview
11.7.3 CYTENA Cell Line Development for Biologics Introduction
11.7.4 CYTENA Revenue in Cell Line Development for Biologics Business (2020-2025)
11.7.5 CYTENA Recent Development
11.8 Molecular Devices
11.8.1 Molecular Devices Company Details
11.8.2 Molecular Devices Business Overview
11.8.3 Molecular Devices Cell Line Development for Biologics Introduction
11.8.4 Molecular Devices Revenue in Cell Line Development for Biologics Business (2020-2025)
11.8.5 Molecular Devices Recent Development
11.9 Samsung Biologics
11.9.1 Samsung Biologics Company Details
11.9.2 Samsung Biologics Business Overview
11.9.3 Samsung Biologics Cell Line Development for Biologics Introduction
11.9.4 Samsung Biologics Revenue in Cell Line Development for Biologics Business (2020-2025)
11.9.5 Samsung Biologics Recent Development
11.10 Hera BioLabs
11.10.1 Hera BioLabs Company Details
11.10.2 Hera BioLabs Business Overview
11.10.3 Hera BioLabs Cell Line Development for Biologics Introduction
11.10.4 Hera BioLabs Revenue in Cell Line Development for Biologics Business (2020-2025)
11.10.5 Hera BioLabs Recent Development
11.11 GTP Bioways
11.11.1 GTP Bioways Company Details
11.11.2 GTP Bioways Business Overview
11.11.3 GTP Bioways Cell Line Development for Biologics Introduction
11.11.4 GTP Bioways Revenue in Cell Line Development for Biologics Business (2020-2025)
11.11.5 GTP Bioways Recent Development
11.12 Abzena
11.12.1 Abzena Company Details
11.12.2 Abzena Business Overview
11.12.3 Abzena Cell Line Development for Biologics Introduction
11.12.4 Abzena Revenue in Cell Line Development for Biologics Business (2020-2025)
11.12.5 Abzena Recent Development
11.13 FyoniBio
11.13.1 FyoniBio Company Details
11.13.2 FyoniBio Business Overview
11.13.3 FyoniBio Cell Line Development for Biologics Introduction
11.13.4 FyoniBio Revenue in Cell Line Development for Biologics Business (2020-2025)
11.13.5 FyoniBio Recent Development
11.14 Catalent
11.14.1 Catalent Company Details
11.14.2 Catalent Business Overview
11.14.3 Catalent Cell Line Development for Biologics Introduction
11.14.4 Catalent Revenue in Cell Line Development for Biologics Business (2020-2025)
11.14.5 Catalent Recent Development
11.15 WuXi Biologics
11.15.1 WuXi Biologics Company Details
11.15.2 WuXi Biologics Business Overview
11.15.3 WuXi Biologics Cell Line Development for Biologics Introduction
11.15.4 WuXi Biologics Revenue in Cell Line Development for Biologics Business (2020-2025)
11.15.5 WuXi Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Lonza
Corning Inc
Sartorius
Thermo Fisher Scientific
Selexis
Beckman Coulter (Danaher)
Cytena
Molecular Devices
Samsung Biologics
Hera BioLabs
GTP Bioways
Abzena
FyoniBio GmbH
Catalent
Wuxi Biologics
List of Tables
 Table 1. Global Cell Line Development for Biologics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of CHO Cell Lines
 Table 3. Key Players of HEK293 Cell Lines
 Table 4. Key Players of Insect Cell Lines
 Table 5. Global Cell Line Development for Biologics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cell Line Development for Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Cell Line Development for Biologics Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Cell Line Development for Biologics Market Share by Region (2020-2025)
 Table 9. Global Cell Line Development for Biologics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Cell Line Development for Biologics Market Share by Region (2026-2031)
 Table 11. Cell Line Development for Biologics Market Trends
 Table 12. Cell Line Development for Biologics Market Drivers
 Table 13. Cell Line Development for Biologics Market Challenges
 Table 14. Cell Line Development for Biologics Market Restraints
 Table 15. Global Cell Line Development for Biologics Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Cell Line Development for Biologics Market Share by Players (2020-2025)
 Table 17. Global Top Cell Line Development for Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Line Development for Biologics as of 2024)
 Table 18. Ranking of Global Top Cell Line Development for Biologics Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Cell Line Development for Biologics Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Cell Line Development for Biologics, Headquarters and Area Served
 Table 21. Global Key Players of Cell Line Development for Biologics, Product and Application
 Table 22. Global Key Players of Cell Line Development for Biologics, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Cell Line Development for Biologics Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Cell Line Development for Biologics Revenue Market Share by Type (2020-2025)
 Table 26. Global Cell Line Development for Biologics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Cell Line Development for Biologics Revenue Market Share by Type (2026-2031)
 Table 28. Global Cell Line Development for Biologics Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Cell Line Development for Biologics Revenue Market Share by Application (2020-2025)
 Table 30. Global Cell Line Development for Biologics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Cell Line Development for Biologics Revenue Market Share by Application (2026-2031)
 Table 32. North America Cell Line Development for Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Cell Line Development for Biologics Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Cell Line Development for Biologics Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Cell Line Development for Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Cell Line Development for Biologics Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Cell Line Development for Biologics Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Cell Line Development for Biologics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Cell Line Development for Biologics Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Cell Line Development for Biologics Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Cell Line Development for Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Cell Line Development for Biologics Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Cell Line Development for Biologics Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Cell Line Development for Biologics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Cell Line Development for Biologics Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Cell Line Development for Biologics Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Lonza Company Details
 Table 48. Lonza Business Overview
 Table 49. Lonza Cell Line Development for Biologics Product
 Table 50. Lonza Revenue in Cell Line Development for Biologics Business (2020-2025) & (US$ Million)
 Table 51. Lonza Recent Development
 Table 52. Corning Company Details
 Table 53. Corning Business Overview
 Table 54. Corning Cell Line Development for Biologics Product
 Table 55. Corning Revenue in Cell Line Development for Biologics Business (2020-2025) & (US$ Million)
 Table 56. Corning Recent Development
 Table 57. Sartorius Company Details
 Table 58. Sartorius Business Overview
 Table 59. Sartorius Cell Line Development for Biologics Product
 Table 60. Sartorius Revenue in Cell Line Development for Biologics Business (2020-2025) & (US$ Million)
 Table 61. Sartorius Recent Development
 Table 62. Thermo Fisher Scientific Company Details
 Table 63. Thermo Fisher Scientific Business Overview
 Table 64. Thermo Fisher Scientific Cell Line Development for Biologics Product
 Table 65. Thermo Fisher Scientific Revenue in Cell Line Development for Biologics Business (2020-2025) & (US$ Million)
 Table 66. Thermo Fisher Scientific Recent Development
 Table 67. Selexis Company Details
 Table 68. Selexis Business Overview
 Table 69. Selexis Cell Line Development for Biologics Product
 Table 70. Selexis Revenue in Cell Line Development for Biologics Business (2020-2025) & (US$ Million)
 Table 71. Selexis Recent Development
 Table 72. Beckman Coulter (Danaher ) Company Details
 Table 73. Beckman Coulter (Danaher ) Business Overview
 Table 74. Beckman Coulter (Danaher ) Cell Line Development for Biologics Product
 Table 75. Beckman Coulter (Danaher ) Revenue in Cell Line Development for Biologics Business (2020-2025) & (US$ Million)
 Table 76. Beckman Coulter (Danaher ) Recent Development
 Table 77. CYTENA Company Details
 Table 78. CYTENA Business Overview
 Table 79. CYTENA Cell Line Development for Biologics Product
 Table 80. CYTENA Revenue in Cell Line Development for Biologics Business (2020-2025) & (US$ Million)
 Table 81. CYTENA Recent Development
 Table 82. Molecular Devices Company Details
 Table 83. Molecular Devices Business Overview
 Table 84. Molecular Devices Cell Line Development for Biologics Product
 Table 85. Molecular Devices Revenue in Cell Line Development for Biologics Business (2020-2025) & (US$ Million)
 Table 86. Molecular Devices Recent Development
 Table 87. Samsung Biologics Company Details
 Table 88. Samsung Biologics Business Overview
 Table 89. Samsung Biologics Cell Line Development for Biologics Product
 Table 90. Samsung Biologics Revenue in Cell Line Development for Biologics Business (2020-2025) & (US$ Million)
 Table 91. Samsung Biologics Recent Development
 Table 92. Hera BioLabs Company Details
 Table 93. Hera BioLabs Business Overview
 Table 94. Hera BioLabs Cell Line Development for Biologics Product
 Table 95. Hera BioLabs Revenue in Cell Line Development for Biologics Business (2020-2025) & (US$ Million)
 Table 96. Hera BioLabs Recent Development
 Table 97. GTP Bioways Company Details
 Table 98. GTP Bioways Business Overview
 Table 99. GTP Bioways Cell Line Development for Biologics Product
 Table 100. GTP Bioways Revenue in Cell Line Development for Biologics Business (2020-2025) & (US$ Million)
 Table 101. GTP Bioways Recent Development
 Table 102. Abzena Company Details
 Table 103. Abzena Business Overview
 Table 104. Abzena Cell Line Development for Biologics Product
 Table 105. Abzena Revenue in Cell Line Development for Biologics Business (2020-2025) & (US$ Million)
 Table 106. Abzena Recent Development
 Table 107. FyoniBio Company Details
 Table 108. FyoniBio Business Overview
 Table 109. FyoniBio Cell Line Development for Biologics Product
 Table 110. FyoniBio Revenue in Cell Line Development for Biologics Business (2020-2025) & (US$ Million)
 Table 111. FyoniBio Recent Development
 Table 112. Catalent Company Details
 Table 113. Catalent Business Overview
 Table 114. Catalent Cell Line Development for Biologics Product
 Table 115. Catalent Revenue in Cell Line Development for Biologics Business (2020-2025) & (US$ Million)
 Table 116. Catalent Recent Development
 Table 117. WuXi Biologics Company Details
 Table 118. WuXi Biologics Business Overview
 Table 119. WuXi Biologics Cell Line Development for Biologics Product
 Table 120. WuXi Biologics Revenue in Cell Line Development for Biologics Business (2020-2025) & (US$ Million)
 Table 121. WuXi Biologics Recent Development
 Table 122. Research Programs/Design for This Report
 Table 123. Key Data Information from Secondary Sources
 Table 124. Key Data Information from Primary Sources
 Table 125. Authors List of This Report


List of Figures
 Figure 1. Cell Line Development for Biologics Picture
 Figure 2. Global Cell Line Development for Biologics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cell Line Development for Biologics Market Share by Type: 2024 VS 2031
 Figure 4. CHO Cell Lines Features
 Figure 5. HEK293 Cell Lines Features
 Figure 6. Insect Cell Lines Features
 Figure 7. Global Cell Line Development for Biologics Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Cell Line Development for Biologics Market Share by Application: 2024 VS 2031
 Figure 9. Monoclonal Antibodies Case Studies
 Figure 10. Recombinant Proteins Case Studies
 Figure 11. Vaccines Case Studies
 Figure 12. Cell Line Development for Biologics Report Years Considered
 Figure 13. Global Cell Line Development for Biologics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Cell Line Development for Biologics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Cell Line Development for Biologics Market Share by Region: 2024 VS 2031
 Figure 16. Global Cell Line Development for Biologics Market Share by Players in 2024
 Figure 17. Global Top Cell Line Development for Biologics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Line Development for Biologics as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Cell Line Development for Biologics Revenue in 2024
 Figure 19. North America Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Cell Line Development for Biologics Market Share by Country (2020-2031)
 Figure 21. United States Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Cell Line Development for Biologics Market Share by Country (2020-2031)
 Figure 25. Germany Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Cell Line Development for Biologics Market Share by Region (2020-2031)
 Figure 33. China Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Cell Line Development for Biologics Market Share by Country (2020-2031)
 Figure 41. Mexico Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Cell Line Development for Biologics Market Share by Country (2020-2031)
 Figure 45. Turkey Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Cell Line Development for Biologics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Lonza Revenue Growth Rate in Cell Line Development for Biologics Business (2020-2025)
 Figure 49. Corning Revenue Growth Rate in Cell Line Development for Biologics Business (2020-2025)
 Figure 50. Sartorius Revenue Growth Rate in Cell Line Development for Biologics Business (2020-2025)
 Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Cell Line Development for Biologics Business (2020-2025)
 Figure 52. Selexis Revenue Growth Rate in Cell Line Development for Biologics Business (2020-2025)
 Figure 53. Beckman Coulter (Danaher ) Revenue Growth Rate in Cell Line Development for Biologics Business (2020-2025)
 Figure 54. CYTENA Revenue Growth Rate in Cell Line Development for Biologics Business (2020-2025)
 Figure 55. Molecular Devices Revenue Growth Rate in Cell Line Development for Biologics Business (2020-2025)
 Figure 56. Samsung Biologics Revenue Growth Rate in Cell Line Development for Biologics Business (2020-2025)
 Figure 57. Hera BioLabs Revenue Growth Rate in Cell Line Development for Biologics Business (2020-2025)
 Figure 58. GTP Bioways Revenue Growth Rate in Cell Line Development for Biologics Business (2020-2025)
 Figure 59. Abzena Revenue Growth Rate in Cell Line Development for Biologics Business (2020-2025)
 Figure 60. FyoniBio Revenue Growth Rate in Cell Line Development for Biologics Business (2020-2025)
 Figure 61. Catalent Revenue Growth Rate in Cell Line Development for Biologics Business (2020-2025)
 Figure 62. WuXi Biologics Revenue Growth Rate in Cell Line Development for Biologics Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Mammalian Cell Line Development Market Research Report 2024
Biotherapeutics Cell Line Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biotech Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cell Line Construction Service Market Research Report 2024
Innovative Biologics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Innovative Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biologics Drug Development Market Research Report 2024
Global Stable Cell Line Development Market Insights Forecast to 2030
Global Innovations in Biologics and Biosimilars Market Research Report 2024
Global Biologics and Biosimilars Market Research Report 2025
Global Cell Line Generation Market Research Report 2025
Cell Culture Bioreactor System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biologic Medical Product Market Research Report 2025
Biologics Drug Discovery and Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biosimilars and Innovative Biological Drugs Market Research Report 2024
Global Cell Line Development Serum Market Research Report 2024
Global CRISPR Cell Line Development Market Research Report 2024
Global Depth Filtration Biologics Manufacturing Market Research Report 2024
Global Mammalian Stable Cell Line Development Services Market Research Report 2025
Global Biologics Outsourcing Services Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions